Indaptus Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Indaptus Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q2 2024.
  • Indaptus Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $129K, a 40.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $129K -$87.2K -40.4% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $151K -$85.4K -36.1% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $173K +$93.9K +118% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $195K +$92.5K +90.5% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $216K +$91K +72.9% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $237K +$89.4K +60.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $79.3K -$89.8K -53.1% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $102K Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $125K Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $147K Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $169K -$648K -79.3% Dec 31, 2021 10-K 2023-03-17
Q4 2020 $817K Dec 31, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.